Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Subcutaneous Normal Saline vs Bacteriostatic Saline
NCT05109000Phase 4Unknown
- Start
- Nov 2021
- Primary completion
- Jan 2022
- Modality
- Injectable Hydrogels, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bacteriostatic sodium chloride 0.9% injection (2 arms). Primary endpoints: Injection Pain at 0 minutes, Erythema at 7 days and 3 more. Status: unknown.
02
Drugs
bacteriostatic sodium chloride 0.9% injection
Beyond the preview
Go deeper on NCT05109000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109000.